One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

OBJECTIVES: To explore the frequency and predictors of flares over 2 years during a treat-to-target strategy with urate-lowering therapy (ULT) in patients with gout. METHODS: In the treat-to-target, tight control NOR-Gout study patients started ULT with escalating doses of allopurinol. Flares were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Uhlig, Till, Karoliussen, Lars F., Sexton, Joe, Kvien, Tore K., Haavardsholm, Espen A., Perez-Ruiz, Fernando, Hammer, Hilde Berner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020166/
https://www.ncbi.nlm.nih.gov/pubmed/35443675
http://dx.doi.org/10.1186/s13075-022-02772-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020166/
https://www.ncbi.nlm.nih.gov/pubmed/35443675
http://dx.doi.org/10.1186/s13075-022-02772-3

Ejemplares similares